Daily CSR
Daily CSR

Daily CSR

Daily news about corporate social responsibility, ethics and sustainability
Tags (3) : cancer innovation

Mary Kay Ash Foundation Grants $500K to Advance Breast Cancer Research & Early Detection

Mary Kay Ash Foundation Grants $500K to Advance Breast Cancer Research & Early Detection
11/17/2025 | Companies
The Mary Kay Ash Foundation, a long-standing advocate for women’s health innovation, has announced a $500,000 grant to the Baylor Scott & White Dallas Foundation. The funding will accelerate a cutting-edge clinical trial for triple-negative breast cancer and support emerging early-detection...
Baylor Scott & White, breast cancer research, cancer innovation, cancer interception, cancer prevention, cancer screening programs, cancer survivorship, Celebrating Women Luncheon, Circle of Care Award, clinical trials, early detection, global cancer initiatives, healthcare partnerships, Joyce O’Shaughnessy, Mary Kay Ash Foundation, medical research funding, metastatic breast cancer research, nonprofit support, philanthropy, TRIM-EBC trial, triple negative breast cancer, women’s empowerment, women’s health

Reclaiming Hope: Gilead's Fight Against Triple-Negative Breast Cancer

Reclaiming Hope: Gilead's Fight Against Triple-Negative Breast Cancer
06/09/2025 | Companies
When Emma received a diagnosis of triple-negative breast cancer, she refused to let it dictate her future. Cancer can take away so much, but at Gilead, we're striving to reclaim what it steals. Our commitment to redefining cancer treatment continues, and we’re excited to present our latest research...
ASCO25, cancer care, cancer innovation, cancer research, cancer resilience, cancer treatment, Gilead, medical breakthroughs, oncology, patient stories, research advancement, triple-negative breast cancer

Advancing Cancer Treatment: Cell Therapy Insights from Kite Pharma

Advancing Cancer Treatment: Cell Therapy Insights from Kite Pharma
04/07/2025 | Companies
We're committed to advancing innovation in virology, oncology, and immunology, with a strong emphasis on supporting groundbreaking science that transforms cancer treatment. In the newest episode of The Centrifuge Sessions, Dr. Samuel Haile, Director of Cell Biology at Kite Pharma, shares insights...
biotechnology, cancer innovation, cancer research, cancer treatment, cell biology, cell therapy, immunology, innovative medicine, Kite Pharma, oncology, patient hope, Samuel Haile, The Centrifuge Sessions, virology


Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com